Market Research Logo

Market for Sepsis Therapeutics and Preventative Agents

159 Pages Kalorama Information November 01, 1995 SKU: AA451

This report from Kalorama Information finds over half a million cases of septicemia are reported annually, and of this number, 45% progress to septic shock. Traces ongoing search for effective treatments and the variety of complications that product developers are experiencing. Covers many new technologies, from antibradykin agents to antitumor necrosis factor products. Product introduction forecasts are provided, based on the regulatory environment and clinical status. Profiles more than 20 leading developers, including Biogen, Cortech, Genentech, Protein Design Labs, and T Cell.

Show Full Description

Show Table of Contents

download product sample

Search inside this report

Pricing & Delivery

Online Download

Didn't find what you are looking for?

Let us find it for you. One of our knowledgeable research assistants will work with you to find exactly the right research to answer your questions:

US: 800.298.5699 International: +1.240.747.3093 Or leave us a message and we'll call you back!

Receive bi-weekly email alerts for new market research.

CTA Image

Download our free eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download CTA

Share this report